Skip to Main Content

Paper Details

Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 Team.
N Engl J Med
187
1999
CD4, CD4 cells, HIV, HIV-1, HIV-1 RNA, HIV-1-infected, Pediatric AIDS, biochemical abnormalities, children, diarrhea, efavirenz, human, human immunodeficiency virus type 1, human immunodeficiency virus type 1 (HIV-1) infection, lymphocyte subpopulations, nelfinavir, neutropenia, nucleoside, nucleoside reverse-transcriptase, plasma, plasma HIV-1 RNA, rash

Datasets

Release 1.2